ENDEAVOR RX
Report
- Report Number
- 9612164-2014-00606
- Event Type
- Injury
- Date Received
- June 10, 2014
- Date of Event
- February 26, 2013
- Report Date
- May 12, 2014
- Manufacturer
- MEDTRONIC IRELAND
- Product Code
- NIQ
- PMA / PMN Number
- P060033
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- PHYSICIAN
Narratives
(B)(4). ROOT CAUSE UNDETERMINED DEVICE/IMAGES NOT RETURNED. MI. NO RESULTS AVAILABLE SINCE NO EVALUATION PERFORMED. DEVICE NOT RETURNED FOR EVALUATION. RESULTS: MI. DEVICE NOT RETURNED. ROOT CAUSE UNDETERMINED DEVICE/IMAGES NOT RETURNED. AGE AT TIME OF EVENT IS THE AVERAGE AGE OF THE PATIENTS. EVENT DATE = DATE OF PUBLICATION. TITLE OF ARTICLE THREE YEAR CLINICAL OUTCOMES WITH ZOTAROLIMUS (ENDEAVOR) DRUG-ELUTING STENTS IN AN UNRESTRICTED CONTEMPORARY PRACTICE. HTTP://DX.DOI.ORG/10.1016/J.IJCARD.2013.01.234.
PATIENTS RECEIVING ENDEAVOR STENTS BETWEEN JUNE 2005 AND FEBRUARY 2007 WERE INCLUDED FOR ANALYSIS. IN TOTAL WE IDENTIFIED 494 PATIENTS WITH 625 LESIONS TREATED WITH 717 ZESS. THIS COHORT INCLUDED A LARGE PERCENTAGE OF HIGH-RISK PATIENTS, INCLUDING PATIENTS WITH DIABETES 31.2%), TARGET LESIONS IN VESSELS LESS THAN 3.0 MM(47.5%), LESIONS GREATER THAN 20 MIN LENGTH (45.5%) AND PATIENTS BEING TREATED FOR ACS (66.2%). ADDITIONALLY, A LARGE NUMBER OF PATIENTS WITH PRIOR PCI (25.3%) AND BYPASS SURGERY (10.3%) WERE REPRESENTED IN THE COHORT. INTERESTINGLY, DESPITE THE PREVALENCE OF HIGH-RISK PATIENTS, THE CUMULATIVE RATES OF CARDIAC DEATHS (4.5%), MIS (6.8%), AND ST (0.9%) WERE EXCEEDINGLY LOW AT 36 MONTHS. THREE CASES OF ARC DEFINITE STENT THROMBOSIS OCCURRED DURING THE STUDY PERIOD, WHICH OCCURRED IN THE FIRST 12 MONTHS. THE 36-MONTH CUMULATIVE RATE FOR TVR WAS 12.2%
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 343242 | ENDEAVOR RX | STENT, CORONARY, DRUG-ELUTING | NIQ | MEDTRONIC IRELAND |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 00065 YR |